These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 38890711)
1. Automated surveillance of antimicrobial consumption in intensive care, northern Sweden: an observational case study. Winroth A; Andersson M; Fjällström P; Johansson AF; Lind A Antimicrob Resist Infect Control; 2024 Jun; 13(1):67. PubMed ID: 38890711 [TBL] [Abstract][Full Text] [Related]
2. Antimicrobial consumption in five adult intensive care units: a 33-month surveillance study. Balkhy HH; El-Saed A; El-Metwally A; Arabi YM; Aljohany SM; Al Zaibag M; Baharoon S; Alothman AF Antimicrob Resist Infect Control; 2018; 7():156. PubMed ID: 30598819 [TBL] [Abstract][Full Text] [Related]
3. Evaluating antimicrobial appropriateness in a tertiary care pediatric ICU in Saudi Arabia: a retrospective cohort study. Kazzaz YM; AlTurki H; Aleisa L; Alahmadi B; Alfattoh N; Alattas N Antimicrob Resist Infect Control; 2020 Nov; 9(1):173. PubMed ID: 33143749 [TBL] [Abstract][Full Text] [Related]
4. The pattern of antibiotic utilisation among intensive care unit patients hospitalised in a Gauteng (South African) provincial tertiary hospital: Comparing findings before and during COVID-19. Spinickum L; Booth Z; Leigh-de Rapper S S Afr Med J; 2024 Jul; 114(7):e1812. PubMed ID: 39041519 [TBL] [Abstract][Full Text] [Related]
5. Automated monitoring compared to standard care for the early detection of sepsis in critically ill patients. Warttig S; Alderson P; Evans DJ; Lewis SR; Kourbeti IS; Smith AF Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012404. PubMed ID: 29938790 [TBL] [Abstract][Full Text] [Related]
6. Antimicrobial consumption in three pediatric and neonatal intensive care units in Saudi Arabia: 33-month surveillance study. Balkhy HH; El-Saed A; AlShehri A; Alshaalan M; Hijazi O; El-Metwally A; Aljohany SM; Al Saif S Ann Clin Microbiol Antimicrob; 2019 Jul; 18(1):20. PubMed ID: 31269955 [TBL] [Abstract][Full Text] [Related]
7. The effect of an antimicrobial stewardship programme in two intensive care units of a teaching hospital: an interrupted time series analysis. Onorato L; Macera M; Calò F; Monari C; Russo F; Iovene MR; Signoriello G; Annibale R; Pace MC; Aurilio C; Gaeta GB; Coppola N Clin Microbiol Infect; 2020 Jun; 26(6):782.e1-782.e6. PubMed ID: 31678230 [TBL] [Abstract][Full Text] [Related]
8. Effects of an automatic discontinuation of antibiotics policy: A novel approach to antimicrobial stewardship. Bolten BC; Bradford JL; White BN; Heath GW; Sizemore JM; White CE Am J Health Syst Pharm; 2019 Sep; 76(Supplement_3):S85-S90. PubMed ID: 31418771 [TBL] [Abstract][Full Text] [Related]
9. Long-Term Effects of Phased Implementation of Antimicrobial Stewardship in Academic ICUs: 2007-2015. Morris AM; Bai A; Burry L; Dresser LD; Ferguson ND; Lapinsky SE; Lazar NM; McIntyre M; Matelski J; Minnema B; Mok K; Nelson S; Poutanen SM; Singh JM; So M; Steinberg M; Bell CM Crit Care Med; 2019 Feb; 47(2):159-166. PubMed ID: 30407951 [TBL] [Abstract][Full Text] [Related]
10. A complete and multifaceted overview of antibiotic use and infection diagnosis in the intensive care unit: results from a prospective four-year registration. De Bus L; Gadeyne B; Steen J; Boelens J; Claeys G; Benoit D; De Waele J; Decruyenaere J; Depuydt P Crit Care; 2018 Sep; 22(1):241. PubMed ID: 30268142 [TBL] [Abstract][Full Text] [Related]
11. Trends in Intensive Care for Patients with COVID-19 in England, Wales, and Northern Ireland. Doidge JC; Gould DW; Ferrando-Vivas P; Mouncey PR; Thomas K; Shankar-Hari M; Harrison DA; Rowan KM Am J Respir Crit Care Med; 2021 Mar; 203(5):565-574. PubMed ID: 33306946 [No Abstract] [Full Text] [Related]
12. A paediatric hospital care AMC report for Northern Ireland. Mallett P; McMichael D; Hsia Y; Moriarty P J Antimicrob Chemother; 2022 Jun; 77(7):2024-2029. PubMed ID: 35451012 [TBL] [Abstract][Full Text] [Related]
13. Effects of implementation of an online comprehensive antimicrobial-stewardship program in ICUs: A longitudinal study. Chen IL; Lee CH; Su LH; Wang YL; Liu JW J Microbiol Immunol Infect; 2018 Feb; 51(1):55-63. PubMed ID: 27553448 [TBL] [Abstract][Full Text] [Related]
14. Antibiotic use and clinical outcomes in the acute setting under management by an infectious diseases acute physician versus other clinical teams: a cohort study. Fawcett NJ; Jones N; Quan TP; Mistry V; Crook D; Peto T; Walker AS BMJ Open; 2016 Aug; 6(8):e010969. PubMed ID: 27554101 [TBL] [Abstract][Full Text] [Related]
15. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
16. Sustained multimodal antimicrobial stewardship in an Australian tertiary intensive care unit from 2008-2015: an interrupted time-series analysis. Adhikari S; Piza M; Taylor P; Deshpande K; Lam D; Konecny P Int J Antimicrob Agents; 2018 Apr; 51(4):620-628. PubMed ID: 29410029 [TBL] [Abstract][Full Text] [Related]
17. "Antimicrobial utilization in a paediatric intensive care unit in India: A step towards strengthening antimicrobial stewardship practices". Singh MP; Gaikwad NR; Keche YN; Jindal A; Dhaneria S; Gurunthalingam MP PLoS One; 2024; 19(9):e0310515. PubMed ID: 39298455 [TBL] [Abstract][Full Text] [Related]
18. A nationwide evaluation of antibiotics consumption in Swedish intensive care units. Sjövall F; Edström M; Walther S; Hanberger H Infect Dis (Lond); 2022 Oct; 54(10):713-721. PubMed ID: 35638173 [TBL] [Abstract][Full Text] [Related]
19. A nationwide survey of intravenous antimicrobial use in intensive care units in Japan. Ohnuma T; Hayashi Y; Yamashita K; Marquess J; Lefor AK; Sanui M; Int J Antimicrob Agents; 2018 Apr; 51(4):636-641. PubMed ID: 29408737 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]